Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation

Clinical trial NCT04711109 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04711109
Sponsor: Alliance for Clinical Trials in Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

BRCA1 Mutation Breast Cancer Breast Diseases Breast Neoplasms Breast Carcinoma Neoplasms

Start date: 2023-02-14
Primary completion: 2027-07-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.